Evidence map›Paper›PMID 20695888›Full record

ArticleThe FEBS journal2010

Angiogenin prevents serum withdrawal-induced apoptosis of P19 embryonal carcinoma cells.

Shuping Li, Wenhao Yu, Hiroko Kishikawa, Guo-fu Hu

Open access · bronzeAbstract read
In one paragraph

Article in The FEBS journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Three decades of research on angiogenin: a review and perspective.Acta biochimica et biophysica Sinica · 2016
    Review
  4. Mechanism and Function of Angiogenin in Apoptosis Regulation.Zhongguo sheng wu hua xue yu fen zi sheng wu xue bao = Chinese journal of biochemistry and molecular biology · 2015
    Article
  5. Article
  6. G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shuping LiDepartment of Pathology, Harvard Medical School, Boston, MA, USA.
Wenhao Yu
Hiroko Kishikawa
Guo-fu Hu
Harvard University · US

Funding

The mechanism of angiogenin-induced angiogenesisR01CA105241 · NCI · TUFTS MEDICAL CENTER · PI HU, GUO-FU · 2005 to 2015
$2.8M
Angiogenin in ALS Pathobiology and TherapyR01NS065237 · NINDS · TUFTS MEDICAL CENTER · PI HU, GUO-FU · 2010 to 2014
$1.8M
NCI NIH HHS CA105241NCI NIH HHS R01 CA105241NINDS NIH HHS NS065237NINDS NIH HHS R01 NS065237
6 · The paper itself

Abstract

Angiogenin is a 14 kDa protein originally identified as an angiogenic protein. Recent development has shown that angiogenin acts on both endothelial cells and neuronal cells. Loss-of-function mutations in the coding region of the ANG gene have recently been identified in patients with amyotrophic lateral sclerosis. Angiogenin has been shown to control motor neuron survival and protect neurons from apoptosis under various stress conditions. In this article, we characterize the anti-apoptotic activity of angiogenin in pluripotent P19 mouse embryonal carcinoma cells. Angiogenin prevents serum withdrawal-induced apoptosis. Angiogenin upregulates anti-apoptotic genes, including Bag1, Bcl-2, Hells, Nf-kappab and Ripk1, and downregulates pro-apoptotic genes, such as Bak1, Tnf, Tnfr, Traf1 and Trp63. Knockdown of Bcl-2 largely abolishes the anti-apoptotic activity of angiogenin, whereas the inhibition of Nf-kappab activity results in a partial, but significant, inhibition of the protective activity of angiogenin. Thus, angiogenin prevents stress-induced cell death through both the Bcl-2 and Nf-kappab pathways.

Indexed as

AnimalsApoptosisCarcinoma, EmbryonalCaspasesCulture Media, Serum-FreeCytochromes cGene Expression Regulation, NeoplasticMiceNF-kappa BProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Recombinant ProteinsReverse Transcriptase Polymerase Chain ReactionRibonuclease, PancreaticTumor Cells, CulturedangiogeninBcl2 protein, mouseCaspasesCulture Media, Serum-FreeCytochromes cNF-kappa BProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Recombinant ProteinsRibonuclease, Pancreatic

Identifiers

PMID20695888
PMCPMC2923675
OpenAlexW1600144078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.